0001104659-17-010600.txt : 20170221 0001104659-17-010600.hdr.sgml : 20170221 20170221172150 ACCESSION NUMBER: 0001104659-17-010600 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170221 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20170221 DATE AS OF CHANGE: 20170221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Marathon Patent Group, Inc. CENTRAL INDEX KEY: 0001507605 STANDARD INDUSTRIAL CLASSIFICATION: PATENT OWNERS & LESSORS [6794] IRS NUMBER: 010949984 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36555 FILM NUMBER: 17626084 BUSINESS ADDRESS: STREET 1: 11100 SANTA MONICA BLVD., STE. 380 CITY: LOS ANGELES STATE: CA ZIP: 90025 BUSINESS PHONE: (800) 804-1690 MAIL ADDRESS: STREET 1: 11100 SANTA MONICA BLVD., STE. 380 CITY: LOS ANGELES STATE: CA ZIP: 90025 FORMER COMPANY: FORMER CONFORMED NAME: American Strategic Minerals Corp DATE OF NAME CHANGE: 20111213 FORMER COMPANY: FORMER CONFORMED NAME: VERVE VENTURES INC DATE OF NAME CHANGE: 20101210 8-K 1 a17-6899_18k.htm 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 


 

Date of Report (Date of earliest event reported): February 21, 2017

 

MARATHON PATENT GROUP, INC.

(Exact Name of Registrant as Specified in Charter)

 

Nevada

 

001-36555

 

01-0949984

(State or other jurisdiction
of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

11100 Santa Monica Blvd., Ste. 380
Los Angeles, CA

 

90025

(Address of principal executive offices)

 

(Zip Code)

 

Registrant’s telephone number, including area code: (800) 804-1690

 

 

(Former name or former address, if changed since last report)

 

Copies to:

Harvey J. Kesner, Esq.

61 Broadway, 32nd Floor

New York, New York 10006

Telephone: (212) 930-9700

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o       Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o       Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o       Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o       Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 7.01        REGULATION FD DISCLOSURE.

 

On February 21, 2017, Marathon Patent Group, Inc. issued a shareholder letter, a copy of which is attached hereto as Exhibit 99.1.

 

The information contained in this Current Report on Form 8-K shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.  The furnishing of the information in this Current Report on Form 8-K is not intended to, and does not, constitute a representation that such furnishing is required by Regulation FD or that the information contained in this Current Report on Form 8-K constitutes material investor information that is not otherwise publicly available.

 

The Securities and Exchange Commission encourages registrants to disclose forward-looking information so that investors can better understand the future prospects of a registrant and make informed investment decisions. This Current Report on Form 8-K and exhibits may contain these types of statements, which are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, and which involve risks, uncertainties and reflect the Registrant’s judgment as of the date of this Current Report on Form 8-K. Forward-looking statements may relate to, among other things, operating results and are indicated by words or phrases such as “expects,” “should,” “will,” and similar words or phrases. These statements are subject to inherent uncertainties and risks that could cause actual results to differ materially from those anticipated at the date of this Current Report on Form 8-K. Investors are cautioned not to rely unduly on forward-looking statements when evaluating the information presented within.

 

ITEM 9.01        FINANCIAL STATEMENTS AND EXHIBITS

 

(d)                                 Exhibits.

 

The exhibit listed in the following Exhibit Index is furnished as part of this Current Report on Form 8-K.

 

Exhibit No.

 

Description

99.1

 

Marathon Patent Group, Inc. Shareholder Letter dated February 21, 2017

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date:  February 21, 2017

 

 

 

MARATHON PATENT GROUP, INC.

 

 

 

 

By:

/s/ Francis Knuettel II

 

 

Name: Francis Knuettel II

 

 

Title: Chief Financial Officer

 

3


EX-99.1 2 a17-6899_1ex99d1.htm EX-99.1

Exhibit 99.1

 

February 21, 2017 08:30 ET

 

Marathon Patent Group Issues Letter to Shareholders

 

LOS ANGELES, CA—(Marketwired - Feb 21, 2017) - Marathon Patent Group, Inc. (NASDAQ: MARA) (“Marathon” or “Company”), an IP licensing and commercialization company, today issued the following shareholder letter.

 

The year 2016 was a record revenue year for Marathon Patent Group. While we have yet to report our full fiscal year end results, year to date revenues at the end of our third quarter were nearly double compared to the prior full year. We remain well positioned for 2017 and expect continued revenue growth.

 

We remain optimistic with regard to the fundamental opportunity ahead of us. Currently, we possess a collective pool of quality assets that far surpasses any other time in our history, consisting of over 12,000 assets compared to just 330 this time last year.

 

Although we try to continually provide current investor communications, much of what happens at Marathon cannot be communicated until an outcome has been reached in a litigation, which typically involves a settlement and the execution of a license. The entire litigation process itself, and settlement negotiations, are governed by strict confidentiality. However, investors need to be able to assess the state of our business and prospects. I assure you that we will do our very best to afford you a proper level of transparency, while not impeding our ability to generate licensing revenues.

 

More often than not, the results of our efforts only become tangible upon the execution of a licensing agreement. A tremendous amount of work often results in a single culminating event. While it may outwardly appear that our business is event driven, it is in fact more of a process with predictable milestones. Currently we are working on licensing initiatives designed to promote a recurring and predictable revenue outlook which will allow enhanced transparency and predictability.

 

With this in mind, we will continue to initiate suits, with more soon to follow. For example, we continue to bring cases like those recently filed by our Munitech IP subsidiary against eight defendants and covering Standard Essential Patents acquired from Siemens AG.

 

I would like to give some selected portfolio updates:

 

·    The Signal IP portfolio - Patents relate to the automotive and related industries in the areas of occupant restraint and safety systems as well as automotive centric communications methodologies including sensing and detection technologies. We have two active cases, one against Fiat Chrysler, which is scheduled for trial in June 2017 in Eastern District of Michigan. The second case is against Toyota and is stayed pending final outcome of IPR proceedings.

 



 

·    CRFD Research - CRFD Research’s wireless technology portfolio represents key enabling wireless technologies in two distinct areas; 1) In-Session Handoff in which active sessions on wireless devices (or wired and Internet connected devices) can be handed off to other wireless devices (or wired and Internet connected devices) with no loss of session history and 2) Mobile Web Content Transformation in which web content is transformed into formats compatible with destination devices and is capable of supporting both secure and unsecure connections. We have four active cases in the District of Delaware against Dish, Hulu, Netflix, and Spotify. The cases are stayed pending the final outcomes of the IPR proceedings.

 

·    Oil & Gas - Approximately 11,000 patent assets relating to oil and gas equipment and services. Licensing discussions have been initiated.

 

·    Munitech IP (Siemens Cellular) - The patents relate to W-CDMA and GSM cellular technology. Significantly, most of the patent families have been declared to be Standard Essential Patents (“SEPs”) with the European Telecommunications Standard Institute (“ETSI”) and/or the Association of Radio Industries and Businesses (“ARIB”) related to Long Term Evolution (“LTE”), Universal Mobile Telecommunications System (“UMTS”), and/or General Packet Radio Service (“GPRS”). On February 13, 2017 complaints were filed in the Regional Court of Dusseldorf in Germany against Google Inc., ZTE Deutschland GmbH, ZTE Services Deutschland, ZTE Corporation, Xiaomi Technology Co. LTD., Telecom Deutschland GmbH, Vodafone GmbH, and Telefonica Germany GmbH & Co. OHG.

 

·    Magnus IP (Siemens “Internet of Things”) - The portfolio is directed toward self-healing control networks for automation systems. The patents are relevant to wireless mesh or home area networks for use in the Internet of Things, or connected home devices and enable simple commissioning, application level security, simplified bridging, and end-to-end IP security. The technology can support a wide variety of Internet of Things enabled devices including lighting, sensors, appliances and security. Licensing discussions have been initiated.

 

·    Traverse Technologies - The portfolio pertains to battery anodes and cathodes using nanostructure techniques. It enables exceptional battery performance and allows for integration of microsystems that enhance overall functionality. The technology utilizes both nano-materials and nanostructures to enhance battery performance. As preparation for initial filings is underway, the ongoing prosecution of the portfolio continues with two patents granted in the last 60 days. The first, German Patent Application No. 11 2009 000 443.1, is titled “High Capacity Electrodes,” and the second, Singapore Patent Application No. 11201405271X, is titled “Hybrid Energy Storage Devices.” Licensing discussions have been initiated.

 



 

·    Motheye - Covers systems that reduce or eliminate reflection at facets of a semiconductor gain medium, as well as suppressing natural longitudinal modes. In addition, the technology enables more precise wavelength control of the light output of a laser. This allows the laser to be used in a dense wavelength division multiplexing system. Licensing discussions are scheduled to commence prior to the end of March 2017.

 

·    Dynamic Advances - The Dynamic Advances portfolio contains patents which relate to a system and method is provided that utilizes a definitive model of enterprise metadata, a design of keywords with simplified complexity, a graphical model of logical structure, a branch and bound search algorithm, and a case-based interaction method to process natural language inputs. Licensing discussions have been initiated.

 

We continue to believe that there are opportunities in brand and trademark licensing and that these opportunities could complement our core patent licensing business. While disappointed an anticipated acquistion has not come to fruition, we continue to evaluate numerous other trademark assets. We remain mindful of finding the right trademark asset for the right price and will only consider those we believe capable of generating a return on investment for our shareholders.

 

Further complementing our core patent listening business, we were fortunate to partner with HP on 3D Nanocolor. The IP exclusively licensed by 3D Nanocolor is a result of years of research and development at HP and is an advancement of HP’s leadership in micro fluid technology. 3D Nanocolor is commercializing HPs disruptive technology that targets the multi-billion commercial smart glass and window markets. EK film being developed is an optical switching technology using the electrically charged ink that can be applied to glass surfaces to enable dynamic control of color and contrast. This novel disruptive technology can be applied to both new and existing windows, offering improved color options, energy savings, and immediate switching response. Importantly, manufacturing and production costs of 3D Nano EK film are expected to be lower when compared to the current leading smart window technology.

 

In recent weeks, we have been meeting with advisors to evaluate a number of options to best allow 3D Nanocolor to drive value to Marathon shareholders, including a potential spin-off or further investment in the assets.

 

We believe that we are well positioned to see continued year over year revenue growth, expecting 2017 revenues to exceed 2016. The quality and size of our managed asset base has never been stronger and provides opportunities for more potential revenue than in prior years, including potential for recurring revenues.

 

In closing, we are grateful for your continued support and look forward to speaking with you on our forthcoming FYE 2016 earnings call.

 



 

About Marathon Patent Group, Inc.

 

Marathon is an IP licensing and commercialization company. The Company acquires and manages IP rights from a variety of sources, including large and small corporations, universities and other IP owners. Marathon has a global focus on IP acquisition and management. The Company’s commercialization division is focused on the full commercialization lifecycle which includes discovering opportunities, performing due diligence, providing capital, managing development, protecting and developing IP, assisting in execution of the business plan, and realizing shareholder value.

 

Forward-Looking Statements

 

Statements made in this press release include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, but not limited to, the amount and use of proceeds the Company expects to receive from the sale of the shares of common stock in the registered direct offering and the closing of the transactions. Forward-looking statements can be identified by the use of words such as “may,” “will,” “plan,” “should,” “expect,” “anticipate,” “estimate,” “continue,” or comparable terminology. Such forward-looking statements are inherently subject to certain risks, trends and uncertainties, many of which the Company cannot predict with accuracy and some of which the Company might not even anticipate, and involve factors that may cause actual results to differ materially from those projected or suggested. Readers are cautioned not to place undue reliance on these forward-looking statements and are advised to consider the factors listed above together with the additional factors under the heading “Risk Factors” in the Company’s Annual Reports on Form 10-K, as may be supplemented or amended by the Company’s Quarterly Reports on Form 10-Q. The Company assumes no obligation to update or supplement forward-looking statements that become untrue because of subsequent events, new information or otherwise.

 

CONTACT INFORMATION

 

·                 CONTACT INFORMATION

 

Marathon Patent Group
Jason Assad
678-570-6791
Email Contact